Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations.

Dooley J, Pauwels I, Franckaert D, Smets I, Garcia-Perez JE, Hilven K, Danso-Abeam D, Terbeek J, Nguyen ATL, De Muynck L, et al.